(VIANEWS) - Arbor Realty Trust (ABR), Fresenius Medical Care AG (FMS), Vertex Pharmaceuticals (VRTX) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Arbor Realty Trust (ABR)
62.5% sales growth and 21.06% return on equity
Arbor Realty Trust, Inc. is an investor in structured finance assets for the commercial, multifamily, and single-family rental markets.
Arbor Realty Trust's sales growth this year is expected to be 50% and 27.9% for next year.
Year-on-year quarterly revenue growth grew by 9.9%, now sitting on 641.23M for the twelve trailing months.
Volume
Today's last reported volume for Arbor Realty Trust is 1565680 which is 22.05% below its average volume of 2008570.
Arbor Realty Trust's sales growth for the next quarter is 62.5%. The company's growth estimates for the present quarter and the next is a negative 38.8% and negative -9.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.06%.
Volatility
Arbor Realty Trust's last day, last week, and last month's current intraday variation average was 1.92%, 1.42%, and 1.00%, respectively.
Arbor Realty Trust's highest amplitude of average volatility was 1.86% (day), 2.03% (last week), and 1.92% (last month), respectively.
Arbor Realty Trust's Stock Yearly Top and Bottom Value
Arbor Realty Trust's stock is valued at $17.52 at 06:22 EST, way under its 52-week high of $20.74 and above its 52-week low of $16.11.
Arbor Realty Trust's Moving Average
Arbor Realty Trust's value is above its 50-day moving average of $17.34 and below its 200-day moving average of $18.06.2. Fresenius Medical Care AG (FMS)
27.6% sales growth and 9.51% return on equity
Fresenius Medical Care AG & Co. KGaA is a company that provides kidney dialysis services and related services. It also offers other healthcare services internationally.
Fresenius Medical Care AG's sales growth this year is expected to be 19.2% and 4.6% for next year.
Year-on-year quarterly revenue growth declined by 5.2%, now sitting on 17.34B for the twelve trailing months.
Fresenius Medical Care AG's sales growth for the next quarter is 27.6%. The company's growth estimates for the ongoing quarter and the next is a negative 26% and negative -24.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.51%.
Volatility
Fresenius Medical Care AG's last day, last week, and last month's current intraday variation average was 0.52%, 0.36%, and 1.21%, respectively.
Fresenius Medical Care AG's highest amplitude of average volatility was 2.27% (day), 2.40% (last week), and 2.05% (last month), respectively.
Fresenius Medical Care AG's Stock Yearly Top and Bottom Value
Fresenius Medical Care AG's stock is valued at $0.00 at 06:22 EST, under its 52-week low of $29.71.
Fresenius Medical Care AG's Moving Average
Fresenius Medical Care AG's value is below its 50-day moving average of $33.36 and below its 200-day moving average of $37.59.3. Vertex Pharmaceuticals (VRTX)
21.3% sales growth and 24.64% return on equity
Vertex Pharmaceuticals Incorporated is involved in the development and marketing of therapies to treat cystic fibrosis.
Vertex Pharmaceuticals's sales growth this year is expected to be 20.8% and 9.4% for next year.
Year-on-year quarterly revenue growth grew by 29%, now sitting on 7.13B for the twelve trailing months.
Volume
Today's last reported volume for Vertex Pharmaceuticals is 1766490 which is 11.22% above its average volume of 1588280.
Vertex Pharmaceuticals's sales growth for the next quarter is 21.3%. The company's growth estimates for the ongoing quarter and the next is 31.5% and 11.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 24.64%.
Volatility
Vertex Pharmaceuticals's last day, last week, and last month's current intraday variation average was 2.30%, 1.26%, and 1.00%, respectively.
Vertex Pharmaceuticals's highest amplitude of average volatility was 4.81% (day), 3.49% (last week), and 2.52% (last month), respectively.
Vertex Pharmaceuticals's Stock Yearly Top and Bottom Value
Vertex Pharmaceuticals's stock is valued at $253.93 at 06:22 EST, way under its 52-week high of $292.75 and way higher than its 52-week low of $176.36.
Vertex Pharmaceuticals's Moving Average
Vertex Pharmaceuticals's worth is under its 50-day moving average of $255.88 and way higher than its 200-day moving average of $215.94.4. MasterCraft Boat Holdings (MCFT)
19.4% sales growth and 61.09% return on equity
MasterCraft Boat Holdings, Inc., via its subsidiaries, designs, produces, and markets recreational motorboats.
MasterCraft Boat Holdings's sales growth this year is anticipated to be 24.7% and 9.5% for next year.
Year-on-year quarterly revenue growth grew by 34.4%, now sitting on 606.86M for the twelve trailing months.
Volume
Today's last reported volume for MasterCraft Boat Holdings is 65739 which is 37.08% below its average volume of 104483.
MasterCraft Boat Holdings's sales growth is a negative 0% for the present quarter and 19.4% for the next. The company's growth estimates for the present quarter and the next is 5% and 67.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 61.09%.
Volatility
MasterCraft Boat Holdings's last day, last week, and last month's current intraday variation average was 0.57%, 1.50%, and 2.04%, respectively.
MasterCraft Boat Holdings's highest amplitude of average volatility was 4.05% (day), 3.33% (last week), and 3.89% (last month), respectively.
MasterCraft Boat Holdings's Stock Yearly Top and Bottom Value
MasterCraft Boat Holdings's stock is valued at $24.15 at 06:22 EST, way below its 52-week high of $33.63 and higher than its 52-week low of $22.08.
MasterCraft Boat Holdings's Moving Average
MasterCraft Boat Holdings's value is below its 50-day moving average of $25.77 and under its 200-day moving average of $26.32.5. Boyd Gaming Corporation (BYD)
11.4% sales growth and 34.28% return on equity
Boyd Gaming Corporation and its affiliates operate as multi-jurisdictional gaming companies.
Boyd Gaming Corporation's sales growth this year is expected to be 52.9% and 3.4% for next year.
Year-on-year quarterly revenue growth grew by 29.3%, now sitting on 3.13B for the twelve trailing months.
Volume
Today's last reported volume for Boyd Gaming Corporation is 804275 which is 35.93% below its average volume of 1255490.
Boyd Gaming Corporation's sales growth for the next quarter is 11.4%. The company's growth estimates for the current quarter and the next is 171.7% and 28%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 34.28%.
Volatility
Boyd Gaming Corporation's last day, last week, and last month's current intraday variation average was 1.93%, 2.68%, and 2.06%, respectively.
Boyd Gaming Corporation's highest amplitude of average volatility was 4.52% (day), 5.38% (last week), and 4.14% (last month), respectively.
Boyd Gaming Corporation's Stock Yearly Top and Bottom Value
Boyd Gaming Corporation's stock is valued at $60.58 at 06:22 EST, way under its 52-week high of $72.72 and way above its 52-week low of $50.38.